Pennant Group [PNTG] vs Pediatrix Medical [MD] Detailed Stock Comparison

Pennant Group, Inc.

NASDAQ
Loading...

Pediatrix Medical Group, Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Pennant Group, Inc. wins in 3 metrics, Pediatrix Medical Group, Inc. wins in 17 metrics, with 0 ties. Pediatrix Medical Group, Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Pennant Group, Inc. Pediatrix Medical Group, Inc. Better
P/E Ratio (TTM) 34.94 11.88 Pediatrix Medical Group, Inc.
Price-to-Book Ratio 3.08 2.16 Pediatrix Medical Group, Inc.
Debt-to-Equity Ratio 122.87 73.29 Pediatrix Medical Group, Inc.
PEG Ratio 0.74 9.90 Pennant Group, Inc.
EV/EBITDA 24.80 7.92 Pediatrix Medical Group, Inc.
Profit Margin (TTM) 3.12% 8.64% Pediatrix Medical Group, Inc.
Operating Margin (TTM) 6.25% 11.07% Pediatrix Medical Group, Inc.
EBITDA Margin (TTM) 6.25% 11.07% Pediatrix Medical Group, Inc.
Return on Equity 9.84% 20.28% Pediatrix Medical Group, Inc.
Return on Assets (TTM) 3.90% 6.57% Pediatrix Medical Group, Inc.
Free Cash Flow (TTM) $36.26M $252.63M Pediatrix Medical Group, Inc.
1-Year Return 19.30% 52.23% Pediatrix Medical Group, Inc.
Price-to-Sales Ratio (TTM) 1.07 1.00 Pediatrix Medical Group, Inc.
Enterprise Value $1.49B $2.00B Pediatrix Medical Group, Inc.
EV/Revenue Ratio 1.57 1.05 Pediatrix Medical Group, Inc.
Gross Profit Margin (TTM) 13.57% 25.51% Pediatrix Medical Group, Inc.
Revenue per Share (TTM) $27 $23 Pennant Group, Inc.
Earnings per Share (Diluted) $0.84 $1.94 Pediatrix Medical Group, Inc.
Beta (Stock Volatility) 1.30 0.72 Pediatrix Medical Group, Inc.
Short % of Float 2.42% 6.00% Pennant Group, Inc.

Pennant Group, Inc. vs Pediatrix Medical Group, Inc. Stock Performance Analysis

Loading Price Chart...

PNTG
MD

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Pennant Group, Inc.-0.76%-10.74%-2.41%-8.09%4.37%9.05%
Pediatrix Medical Group, Inc.2.43%0.88%-2.54%10.64%-6.23%2.58%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Pennant Group, Inc.19.30%176.21%1.75%114.06%114.06%114.06%
Pediatrix Medical Group, Inc.52.23%53.97%-32.60%-68.09%-39.53%-4.27%

Performance & Financial Health Analysis: Pennant Group, Inc. vs Pediatrix Medical Group, Inc.

MetricPNTGMD
Market Information
Market Cap i$1.05B$1.91B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i152,152510,889
90 Day Avg. Volume i226,704755,756
Last Close$30.12$22.37
52 Week Range$21.73 - $37.54$11.84 - $24.99
% from 52W High-19.77%-10.48%
All-Time High$69.56 (Jan 04, 2021)$86.09 (Aug 17, 2015)
% from All-Time High-56.70%-74.02%
Growth Metrics
Quarterly Revenue Growth0.53%-0.02%
Quarterly Earnings Growth0.50%0.11%
Financial Health
Profit Margin (TTM) i0.03%0.09%
Operating Margin (TTM) i0.06%0.11%
Return on Equity (TTM) i0.10%0.20%
Debt to Equity (MRQ) i122.8773.29
Cash & Liquidity
Book Value per Share (MRQ)$9.54$10.68
Cash per Share (MRQ)$0.49$6.16
Operating Cash Flow (TTM) i$48.29M$271.09M
Levered Free Cash Flow (TTM) i$7.21M$190.33M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Pennant Group, Inc. vs Pediatrix Medical Group, Inc.

MetricPNTG (Apr 24, 2026)MD (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i34.9411.88
Forward P/E i18.719.90
PEG Ratio i0.749.90
Price to Sales (TTM) i1.071.00
Price to Book (MRQ) i3.082.16
Market Capitalization
Market Capitalization i$1.05B$1.91B
Enterprise Value i$1.49B$2.00B
Enterprise Value Metrics
Enterprise to Revenue i1.571.05
Enterprise to EBITDA i24.807.92
Risk & Other Metrics
Beta i1.300.72
Book Value per Share (MRQ) i$9.54$10.68

Financial Statements Comparison: Pennant Group, Inc. vs Pediatrix Medical Group, Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricPNTG (2025)MD (2025)
Revenue/Sales i947.71M1.91B
Cost of Goods Sold i817.20M1.42B
COGS % of Revenue i86.2%74.2%
Gross Profit i130.50M493.70M
Gross Margin i13.8%25.8%
Research & Development iN/AN/A
Operating Income (EBIT) i50.89M231.09M
Operating Margin i5.4%12.1%
EBITDA i59.85M256.55M
EBITDA Margin i6.3%13.4%
Pre-Tax Income i45.63M216.43M
Pre-Tax Income % of Revenue i4.8%11.3%
Income Tax i11.87M51.04M
Income Tax % of Revenue i1.3%2.7%
Net Income (Profit) i33.76M165.39M
Profit Margin i3.6%8.6%

Balance Sheet & Liquidity Metrics

MetricPNTG (2025)MD (2025)
Cash & Equivalents i17.02M375.24M
Total Current Assets i167.41M763.51M
Total Current Assets % of Revenue i17.7%39.9%
Total Current Liabilities i147.26M458.91M
Total Current Liabilities % of Revenue i15.5%24.0%
Long-Term Debt i423.15M596.22M
Long-Term Debt % of Revenue i44.6%31.2%
Total Shareholders Equity i374.25M865.85M
Retained Earnings i86.80M-83.15M
Retained Earnings % of Revenue i9.2%-4.3%
Property, Plant & Equipment i313.64M195.53M

Cash Flow Statement Comparison

MetricPNTG (2025)MD (2025)
Operating Cash Flow i33.89M270.23M
Operating Cash Flow % of Revenue i3.6%14.1%
Capital Expenditures i-12.04M-18.46M
Free Cash Flow i36.26M252.63M
FCF Margin i3.8%13.2%
Debt Repayment i-298.00M-20.75M
Common Stock Repurchase iN/A-86.68M

Short Interest & Institutional Ownership Analysis

MetricPNTGMD
Shares Short i797,4563.53M
Short Ratio i3.003.77
Short % of Float i2.42%6.00%
Shares Outstanding i34.63M82.98M
Float Shares i33.00M79.95M
% Held by Insiders i5.00%2.31%
% Held by Institutions i97.01%106.63%
% Held by Public i-2.01%-8.94%

Dividend Analysis & Yield Comparison: Pennant Group, Inc. vs Pediatrix Medical Group, Inc.

MetricPNTGMD
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A